A pilot study of the effects of metacognition-oriented social skills training (MOSST) on social functioning in patients with schizophrenia spectrum disorders (SSDs) reported promising results. The main purpose of the current trial was to compare the effectiveness and potential benefits of MOSST vs conventional social skills training (SST). Single-blind randomized controlled trial with 2 groups of patients aged 18-65 with SSDs on partial hospitalization. Participants were randomly assigned (1:1) to receive 16 group sessions with MOSST or conventional SST, both in addition to standard care, over 4 months, with a 6-month follow-up. Psychosocial functioning, metacognition, and symptom outcomes were measured by blind assessors. Statistical analyses used mixed models to estimate treatment effects in each postrandomization time point. Thirty-six patients were randomly assigned to the MOSST group and 33 patients to the conventional SST group. Between-group differences were significant in favor of MOSST on Social and Occupational Functioning Assessment Scale (SOFAS) and Personal and Social Performance Scale (PSP) total scores at post-treatment and follow-up. Concerning PSP subscales, there were significant between-group differences in favor of MOSST at follow-up on socially useful activities, personal and social relationships, and disturbing and aggressive behaviors. Metacognition only improved following MOSST group. For people with SDDs, MOSST appears to have shortand long-term beneficial effects on social functioning and symptoms. Further studies are required to replicate the current results in other samples.
Introduction
Interacting with others, understanding the social environment, and developing successful interpersonal relationships are particularly challenging for people with schizophrenia spectrum disorders (SSDs).
1,2 As a consequence, social skills training (SST) has emerged as a validated intervention and is recommended in guidelines for these disorders. 3 Unfortunately, many studies have revealed that the effects and generalizability of standard SST are poorer than desired regarding social functioning. 4 Hence, a recent Cochrane Collaboration Review 3 concluded that, to date, it remains unclear whether current SST programs are more effective than standard care. There is, therefore, a need to develop new treatments for social dysfunction in this population. 5 For instance, Granholm et al 5, 6 have shown promising results combining SST with cognitive-behavioral therapy (CBT) in adults with schizophrenia. The past decades saw the emergence of many studies focusing on metacognition as a core mechanism involved in adaptive social functioning in SSDs. 7 Metacognition refers to the range of mental activities that allow people to be aware of and reflect upon their own thoughts, feelings, and intentions, and those of other people, and ultimately formulate connections between these events into larger complex representations of themselves and others. 8 This set of abilities has been referred to using different, often overlapping, terms such as "social cognition" or "mentalization." 9 Throughout this work, the term of metacognition will be used as an "umbrella" construct for all the processes related to knowledge of mental use and their application for purposeful problem solving in the realm of social interactions. A wealth of evidence shows that individuals with SSDs have deficits on more discrete facets of metacognition such as the perception of emotional information, 10 as well as more synthetic aspects of metacognition, such as the ability to integrate information into larger representations of oneself and others. 11 Moreover, metacognitive deficits have been hypothesized to be the proximal mechanism underlying symptoms and social functioning in the presence of neurocognitive deficits. 12, 13 Based on this body of knowledge, psychotherapies based on metacognition have been designed 14, 15 and successfully tested in preliminary studies with patients with SSDs. 16 There is sufficient evidence to think that remediating metacognition may be an imperative component of effective SST. However, many existing SST interventions almost entirely neglect the promotion of metacognitive abilities. 17 In light of this, Ottavi et al 18 have developed a novel metacognition-oriented SST (MOSST) intervention that includes metacognitive remediation as a means of improving the effectiveness of conventional SST for patients affected by psychosis. 19 To date, MOSST has been used with a small group of patients with long-term schizophrenia on partial hospitalization or with firstepisode psychosis 19 and in a case illustration that showed successful outcomes after completing the program. 18 Recently, a pilot study developed as a precursor to this trial found that MOSST produced large effects on social functioning (d = −0.83) and metacognition (d = −0.73). 20 Though results from the pilot study were encouraging, the effectiveness of this intervention compared with standard SST has yet to be investigated using a randomized controlled trial.
The current trial was designed to compare the acceptability, effectiveness, and potential benefits of a group intervention based on MOSST to that of conventional SST in outpatients with SSDs. The hypotheses were as follows. First, we predicted that the MOSST intervention would lead to superior improvements in social functioning than those observed following a standard SST intervention. Second, we predicted that participants' metacognitive skills would only improve following MOSST. Third, we hypothesized that MOSST would have no direct effect on psychotic symptoms but would have some effects on mood and anxiety.
Methods

Trial Design
This study was a single-blind, randomized, controlled trial conducted between July 1, 2014, and December 31, 2016, at 2 partial hospitals in Navarra, a region located in the north of Spain. Participants were randomly assigned (1:1) with permuted block sizes of 3 or 5, to receive MOSST or conventional SST, both in addition to treatment as usual (TAU). TAU consisted of standard care and regular clinical management with participants' usual psychiatrists, clinical psychologists, and occupational therapists and was not affected by the trial protocol. Participants' social, occupational and personal functioning, metacognitive abilities, and disorder-specific clinical symptoms were assessed at 0 months (baseline), not before 4 months later (post-treatment), and 6-month follow-up.
Randomization was first stratified by study site, gender, and duration of illness (in years) to control for potential bias. The allocation of therapists was conducted via email. Procedures were adopted to achieve masked ratings: evaluators were not involved in the randomization process, and this process was completely independent; therapists were required to use diary arrangements in view of potential blind breaks; and patients were reminded by researchers not to talk about treatment allocation. When masking was broken, another rater assessed the participant for all subsequent assessments or the ratings were discussed with a new masked rater and consensus reached. The trial protocol was given ethical approval by the Institutional Ethical Committee (Ref. 0106/14) and was registered as ISRCTN10917911.
Sample-Size Calculation
Considering the effect sizes of MOSST reported in a previous pilot study, 20 power analyses were based on obtaining large effect sizes (d > 0.70) in the primary outcome measures. 21, 22 To detect effects of at least this magnitude, using an independent samples t test at a conservative alpha of .05 (2-tailed), it was estimated that a minimum sample size of 32 per group was required. Assuming a 15% drop-out rate, a sample of 37 patients per group was needed.
Participants
Eligible participants aged 18-65 years were receiving psychosocial rehabilitation and either met International Classification of Diseases-tenth revision (ICD-10) criteria for schizophrenia, schizoaffective disorder, or delusional disorder, as determined by trained Psychiatrists or Clinical Psychologists through clinical interview. Participants were eligible if they had been clinically stable and treated with a consistent dose of the same antipsychotic medication for a period of at least 2 months prior to the intervention. Participants were included if they demonstrated social engagement problems and poor participation in social activities, established via case manager reports. The case managers of eligible patients were also consulted about whether each case might be suitable for inclusion in the trial, when their individualized treatment plan was considered. Participants were excluded if they had concomitant substance abuse, moderate to severe learning disabilities or developmental disorders, major neurological illness, impaired intellectual functioning (Wechsler Adult Intelligence Scale-IV Full-Scale IQ score < 70), or did not have the capacity to consent to research participation.
Trial Therapists
There were 6 trial therapists with over 4 years' experience in group therapy and versed in conventional SST. All sessions were conducted by at least 2 therapists. In the MOSST condition, therapists received a specific prior 4-day training program on metacognition-oriented therapy 14, 15, 23 and on the use of the Metacognitive Assessment Scale-Abbreviated (MAS-A) in psychosis. 20 The training was delivered by the principal investigator for all therapists.
Outcome Measures
Primary Outcomes. Psychosocial functioning was assessed with the Social and Occupational Functioning Assessment Scale (SOFAS) 24, 25 and the Personal and Social Performance Scale (PSP). 26 The Spanish PSP and SOFAS have proved to be reliable, valid, and sensitive instruments for the assessment of psychosocial functioning in schizophrenia. 27 The Cronbach's alpha coefficients of the SOFAS and PSP scores thorough the trial were optimal (mean = 0.82; SD = 0.09). Metacognition was assessed with the MAS-A. 8, 28 The MAS-A is a rating scale for assessing different forms of metacognitive activity within personal narratives. It contains 4 subscales: "Self-reflectivity," "Understanding the other's mind," "Decentration," and "Mastery." Higher scores on the subscales indicate higher capacity to integrate and effectively use intersubjective information. 29 Participants' narratives were obtained using the Spanish adaptation of the Metacognition Assessment Interview (MAI). 8 In this trial, inter-rater reliability for MAS-A scores revealed a significant intra-class correlation for all 4 subscales ranging from r = .74 (P < .05) for 'Decentration' to r = .93 (P < .01) for the total score. Secondary Outcomes. Psychotic symptoms were assessed with the Spanish adaptation of the Positive and Negative Syndrome Scale (PANSS). 30 Inter-rater reliability between 2 blind raters was assessed regularly throughout the trial obtaining adequate inter-rater reliabilities (mean = 0.87; SD = 0.11). Depression and anxiety were rated to control for emotional distress using the Spanish adaptations of the Beck Depression Inventory-II (BDI-II) 31, 32 and the Beck Anxiety Inventory (BAI), 33, 34 respectively. In this trial, Cronbach's alpha coefficients indicated adequate reliability values (mean = 0.83, SD = 0.13). Acceptability and subjective impacts of the interventions were assessed by an anonymous self-report scale at the end of each session to evaluate the session's enjoyableness, usefulness, and effect on daily social functioning using a 5-point scale (1) (2) (3) (4) (5) .
Procedures
All participants were systematically recruited via care managers from both participating mental healthcare centers. Over a period of 30 months, research assistants contacted all case managers to identify potentially eligible participants. When individuals provided consent, research assistants then checked health care records to assess eligibility in relation to study criteria. Prior to performing the baseline assessments, all evaluators were trained in the administration of the rating scales used in the study and an acceptable inter-rater reliability was attained for each variable. Eligible participants were randomized immediately after the completion of baseline assessments. Before inclusion, all patients were required to sign an informed consent form.
Interventions
All participants followed their routine treatment and were offered the opportunity to participate in the intervention groups. The MOSST intervention followed the 16 weekly group-session protocol adopted in the Spanish adaptation of the intervention 35 and used in the previous pilot study. 20 The conventional SST intervention 36 involved a parallel 16 weekly group-based intervention but the therapists did not assist or stimulate participants' metacognition at any time. All therapy sessions lasted approximately 90 minutes and adhered to original protocol manuals. The target social skills comprised (1) conversation skills such as listening to others, greeting others, starting and ending conversations, and maintaining conversations; (2) assertiveness skills such as making and refusing requests, making and receiving compliments, asking for information, suggesting activities to other people, and expressing unpleasant and positive feelings; and (3) conflict management skills such as compromise and negotiation, making productive complaints, responding to negative complaints, and making apologies.
The number of participants per group ranged between 8 and 12 (mean = 10.62, SD = 2.51). This was so that groups would be broad enough to be stimulating and produce an atmosphere of cooperation among group members, but not too large as to be chaotic or marginalizing for more introverted participants. This group size is in line with SST intervention guidelines 37, 38 and it was also considered cost-effective taking into account the usual number of patients in the public mental healthcare contexts. Fidelity to treatment protocols was ensured by fortnightly face-to-face supervision between therapists, and transcripts of sessions were randomly selected to be analyzed by independent assessors. Therapy supervision was provided by regular meetings between therapists and the principal investigator. The minimal exposure to both treatment protocols for post-test analysis was considered to be 8 or more sessions.
Statistical Analysis
Linear mixed (covariance pattern) with unstructured covariance matrices were fitted using SAS PROC MIXED to allow for correlations between post-treatment and follow-up measures of the same variables. Otherwise identified as marginal models, this approach is equivalent to fitting models with random intercepts that vary at the level of study participants. Maximum likelihood estimation procedures ensure that inferences will remain unbiased under the missing at random assumption. Analyses were adjusted for baseline response. Time and treatmentby-time interaction terms were retained in all models and group differences estimated at each postrandomization time point. Residual diagnostics were conducted to check violations of normality assumptions. Post-treatment and follow-up effect sizes based on adjusted treatment means were computed using Cohen's d along with 95% confidence intervals. The same approach was adopted for the primary and secondary outcomes. Self-rated "utility" and social functioning calculations were performed on 5 sessions taken at regular intervals, using the Friedman test for nonparametric repeated measures. Figure 1 shows the trial CONSORT diagram. After exclusion of candidates who did not meet the study criteria, 36 participants (20 males) were randomly assigned to the MOSST group and 33 (18 males) to the conventional SST group.
Results
Participant Flow and Characteristics
The characteristics of the participants allocated to the 2 trial arms were similar in terms of demographic variables, duration of illness, mean age at first contact with mental health services, education, IQ scores, and diagnoses (see table 1 ).
The mean number of therapy sessions for those allocated to the MOSST group was 13. 33 (100%) in the conventional SST received at least 8 sessions of each intervention, which is considered the minimal exposure to the interventions. Table 2 presents means and SD for all the outcome variables at baseline, post-treatment and 6 months after the end of the interventions. Table 3 shows estimations of treatment effects for the MOSST group relative to the SST group. There were statistically significant betweengroup differences at post-treatment with large effect sizes in favor of MOSST on the SOFAS (P < .01, betweengroup d = 1.63) and PSP total (P < .01, between-group d = 1.03). This superior effect of MOSST remained significant at follow-up assessment with large effect sizes on both the SOFAS (P < .01, between-group d = 1.43) and PSP total scores (P < .01, between-group d = 0.88). Note: Data are mean (SD) or n (%). MOSST, metacognition-oriented social skills training; SST, usual social skills training; WAIS-IV, Wechsler Adult Intelligence Scale-IV. Concerning PSP subscales, there were statistically significant between-group differences with large effect sizes in favor of MOSST at follow-up on socially useful activities, personal and social relationships, and disturbing and aggressive behaviors (P < .01). There were significant between-group differences on the MAS-A total scores with large effect sizes in favor of MOSST at post-treatment and follow-up assessment (P < .01). By subscales, statistically significant improvements on Self-reflectivity and Understanding others' mind with medium effect sizes in favor of MOSST were found at both post-treatment and follow-up assessments (P < .01). Additionally, a significant improvement on Decentration with a medium effect size in favor of MOSST was found at post-treatment (P < .01, betweengroup d = 0.68).
Primary Outcomes
Secondary Outcomes
For the secondary outcome variables, there were significant between-group differences on the BDI-II and BAI mean scores with large or medium effect sizes in favor of MOSST at both post-treatment and follow-up assessments (P < .01). No between-group differences emerged on any of the PANSS subscale scores. Despite a superior trend decrease within the MOSST group both at post-treatment and follow-up, the relative evolution of the PANSS partial scores were not statistically different between-groups (P > .01).
Finally, participants rated the subjective efficacy of both groups as "good" for all items, specifically for the item "utility regarding sessions" (MOSST group mean = 4.00, SD = 0.80; SST group mean = 3.50, SD = 0.90) and the item "daily social functioning after sessions" (MOSST group = 4.50, SD = 1.10; SST group = 4.00, SD = 1.00). As shown in figure 2, Friedman's test revealed a significant difference regarding the MOSST group and time interaction, on the item "daily social functioning after sessions" (F 4 = 12.30, P = .019).
Discussion
The current study is the only clinical trial to date that has aimed to evaluate the effectiveness of a group intervention based on MOSST vs conventional SST in individuals with SSDs. Our sample was comparable to other samples that have been used to investigate SST previously in terms of severity of symptoms and social dysfunction. 4, 39 Baseline levels of metacognition were also consistent with those from similar samples in other countries 7, 11, 40 Almost 100% of participants received the assigned treatment. There was only one drop-out, which was caused by clinical relapse during intervention in the MOSST condition. Therefore, the drop-out rate (3%) was ES measures change from baseline in MOSST relative to SST. Negative estimates show that, on average, scores for the MOSST group were better than those for the SST group, except for MAS-A subscales, SOFAS, and PSP total, for which a positive value is preferable. *P < .01.
well below that obtained in the previous pilot study 20 and in other similar studies. 41 A speculative explanation for such a positive adherence to treatment may be that, as described in the treatment protocol, 35 motivation was specifically worked on in an individual introductory session before starting the groups in both conditions (ie, potential advantages of successfully completing the program). Another additional explanation may be that participant centers are located in rural areas. This required patients to be transferred by relatives or by a specific bus service from their homes to the mental healthcare centers.
The rate of acceptability and subjective impact of MOSST were adequate on all 10 parameters assessed. All patients who completed the full protocol rated the program as useful, generalizable to the real world, recommendable to others, and enjoyable. Patients also rated positively the metacognitive approach of MOSST and, compared with the SST group, participants who received MOSST subjectively judged sessions as more useful for their daily social functioning. It may be that this was because MOSST helped them to deepen their understanding of the mentalistic contents of social environments.
As primarily hypothesized, participants who received MOSST improved their psychosocial functioning, obtaining large effect sizes following MOSST relative to SST at the 6-month follow-up assessment. Particularly noteworthy outcomes observed at 6 months were the maintenance of increased functioning related to useful social activities, the extension of interpersonal relationships, and the substantial reduction of active avoidance as well as disturbing and aggressive behaviors. These findings are in line with those reported by Ottavi et al. 18 As secondarily predicted, only MOSST improved participants' self-reflectivity and ability to understand the minds of others. Although MOSST also produced improvements in decentration at post-treatment, these changes were weak and disappeared after 6 months. In spite of the reduced length of MOSST, these findings revealed a pattern of metacognitive gains consistent with the previous case report on MOSST, 18 as well as with results obtained in other metacognitively oriented psychotherapies. 23 MOSST also seems to help patients to understand that their own thoughts are subjective experiences separate from the mind of others and that their internal expectations do not have a direct effect on reality.
It is likely that the large effect of MOSST on psychosocial functioning can be explained in terms of metacognitive gains. If patients are more aware of their own mental states and those of others, they might reflect on whether their relationships are supportive of their own needs and the needs of others and, if not, whether they need to modify their behavior accordingly. In addition, they may increase their awareness of the pleasant experiences that are derived from social interactions, as well as any negative emotions that may underlie their difficulties in sustaining relationships, such as experiencing feelings of anxiety or shame, which may allow them to develop appropriate strategies. Either way, the role of metacognition as moderator and/or mediator of change has not been specifically analyzed in this trial and future research should focus on how gains in metacognition might promote psychosocial functioning in patients with SSDs.
Though clearly our trial outperformed conventional SST for psychosis with respect to improvements in psychosocial functioning, 3, 4, 42 this outcome may be due to the fact that the effects of metacognitive feedback were controlled for in this study. Thus, therapists in the standard SST condition were instructed not to offer any kind of metacognitive information to patients during group sessions. In this condition, socially effective behaviors were systematic training following the theories of behavior modification, and therapists' feedback could exclusively be focused on the observable behavior of participants. 43 In clinical contexts, however, group therapists routinely offer metacognitive content in a more or less systematized way, regardless of the SST program followed. Because the aim of this trial was to compare 2 SST interventions with and without metacognitive orientation, it is likely that the impact of standard SST was underestimated due to the absence of metacognitive feedback. We consider that the results of our trial do not question the effectiveness of routine SST programs but suggest that including metacognitive content in a systematic way in these interventions has greater utility.
We also evaluated symptoms of psychosis as secondary outcomes, as well as depression and anxiety. Unsurprisingly, there was no differential treatment effect in relation to psychotic symptoms; thus, participants in both groups improved their positive and negative symptomatology. The absence of effects on psychotic symptoms may be easily explained by the fact that MOSST was not specifically tailored to deal with positive symptoms. However, as Bargenquast and Schweitzer 44 indicate, promoting a more complex understanding of oneself may produce an increase in a subjective sense of recovery as well as improving one's ability to manage psychotic symptoms, despite clear improvements not being achieved following treatment. Regarding negative symptoms, although individual long-term CBT, ranging from 16 to 81 individual sessions over 9-18 months of treatment, has been shown to be superior to MOSST in reducing the severity of negative symptoms, 45, 46 the results of this trial point to the possibility that MOSST may be more cost-effective to reduce negative symptoms. Either way, this point is still speculative and requires further research, for instance, to compare the cost-effectiveness of MOSST vs group-based CBT-SST.
Another important question is whether MOSST is more effective than other forms of metacognitive interventions applied to psychosis, such as metacognitive training (MCT). However, the aims of MCT are different from MOSST, as it has a different emphasis. 47, 48 MCT has been applied to reduce positive symptoms and in particular paranoid ideations, and it exerts weak to moderate effects on these targets. 49 Given that MOSST and MCT target different symptoms of psychosis and focus on different elements of the metacognitive system, we do not consider them to be rival approaches, but as treatments that can be delivered in parallel or in sequence to address the difficulties frequently experienced by those with schizophrenia.
As we predicted in the third hypothesis, there were significant relative reductions of emotional distress within the MOSST group. For depression, these findings are consistent with the literature suggesting that improvement in interpersonal functioning 50 and metacognition 51 reduce depressive symptoms. For anxiety, it is plausible that participants may have experienced improvements in emotional self-regulation associated with increased metacognitive abilities. 52 Future research should investigate how MOSST interacts with other metacognitive psychotherapies to improve clinical symptoms and/or recovery. 44 Consistent with person-centered approach to psychosis, 53 instead of trying to correct cognitive distortions underlying positive symptoms, therapy might help people with psychosis to deal with the consequences of symptoms, which include depression, anxiety and social avoidance. Indeed, MOSST may help patients to discover that they can still live a meaningful life instead of being passive and fearful of social interactions.
Several limitations must be acknowledged. Further research is needed to replicate the current findings in samples with different sociodemographic and clinical characteristics, such as young adults with early psychosis. Additionally, it is necessary to evaluate whether metacognition is the mechanism of change. Finally, this study did not control for baseline neuropsychological functioning. Given the metacognitive emphasis of the intervention, it may be that participants with more pronounced cognitive difficulties require cognitive remediation before MOSST to benefit fully, and this is an important topic for further study.
With replication, this study could have important clinical implications. Our results suggest that a relatively short program, focused on metacognition, may lead to sustained improvements in social functioning for people with schizophrenia. A promising area for further research is whether MOSST in combination with other programs, such as MCT for positive symptoms or individual metacognition-oriented psychotherapies, may lead to even greater improvements in outcomes. For those with schizophrenia, MOSST is a promising treatment that may promote people's capacity for metacognition and ability to have a meaningful social life.
